PBS affiliates ... “Ask Me About My Hero: A Gold Star Family Documentary,” by American Veterans Media, is currently available for public screenings and purchase on DVD. (PEG DEGRASSA ...

Antiques Roadshow is available to stream on pbs.org and the free PBS App ... APPRAISER: There's $700 of gold here. (chuckles) APPRAISER: Yeah, and, and that's just scrap. GUEST: (chuckles ...

Check out Michael Larsen’s appraisal of a Georg Jensen gold necklace, ca. 1960, in Living History Farms, Hour 3. Antiques Roadshow is available to stream on pbs.org and the free PBS App ...

If things are best judged by their enemies, not their friends, then Australia’s Pharmaceutical Benefits Scheme (PBS) just received a major tick of approval! The powerful American lobby group for ...

Ronny Jackson, R-Texas, is introducing a bill Thursday to pull all government funding from "chronically biased" outlets NPR and PBS, which he says have been "pushing Democrat talking points under ...

PBS medicines will cost a maximum of $25 if Labor wins the next election, down from $31.60. The move comes as American medical giants take aim at the PBS, describing it as an "egregious and ...

“Let’s be clear, that US free trade agreement was negotiated by the Coalition and the protections for the PBS were put in place for them. “The protections that currently exist for the PBS ...

Pretty much every show you see on PBS is produced by a leftist and they are paid handsomely with tax dollars to make it. Then, when the DVDs or digital copies go on sale, we don’t recoup our ...

You've probably heard a lot about something called the Pharmaceutical Benefits Scheme (PBS) this week. It's been in the news because both sides of parliament announced they'll drop the cost of PBS ...

Rep. Marjorie Taylor Greene on Wednesday used a DOGE subcommittee hearing to call for the defunding and dismantling of the company that provides NPR and PBS with federal funds. For Taylor Greene ...

Health Minister Mark Butler discusses Labor’s slashing of PBS script maximums to $25 dollars and America’s big pharma labelling the program as “egregious and discriminatory".